These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 6871843)

  • 1. Sequence-dependent synergism between dichloromethotrexate and 5-fluorouracil in a human colon carcinoma cell line.
    Sobrero AF; Bertino JR
    Cancer Res; 1983 Sep; 43(9):4011-13. PubMed ID: 6871843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequence-dependent synergism between dichloromethotrexate and cisplatin in a human colon carcinoma cell line.
    Sobrero AF; Bertino JR
    Cancer Treat Rep; 1985 Mar; 69(3):279-83. PubMed ID: 4038918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Susceptibility of human colon carcinoma cells to anticancer drugs is enhanced by L-histidinol.
    Warrington RC; Cheng I; Fang WD
    Anticancer Res; 1994; 14(2A):367-72. PubMed ID: 8017835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro synergism between 5-fluorouracil and natural beta interferon in human colon carcinoma cells.
    Guglielmi A; Aschele C; Mori A; Baldo C; Russo P; Debernardis D; Valenti M; Bruno S; Taverna M; Rosso R
    Clin Cancer Res; 1995 Nov; 1(11):1337-44. PubMed ID: 9815929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination chemotherapy in vitro. IV. Response of human colon carcinoma cells to combinations using cis-diamminedichloroplatinum.
    Bergerat JP; Green C; Drewinko B
    Cancer Biochem Biophys; 1979; 3(4):173-80. PubMed ID: 575983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequence dependent synergistic cytotoxicity between etoposide and fluoropyrimidines.
    Damon LE; Christensen S; Rochlitz C; Cadman EC
    Anticancer Res; 1989; 9(6):1761-7. PubMed ID: 2534035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folinic acid augmentation of the effects of fluoropyrimidines on murine and human leukemic cells.
    Keyomarsi K; Moran RG
    Cancer Res; 1986 Oct; 46(10):5229-35. PubMed ID: 2944577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Schedule-dependent synergism and antagonism between paclitaxel and methotrexate in human carcinoma cell lines.
    Kano Y; Akutsu M; Tsunoda S; Furuta M; Yazawa Y; Ando J
    Oncol Res; 1998; 10(7):347-54. PubMed ID: 10063968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determinants of cytotoxicity with prolonged exposure to fluorouracil in human colon cancer cells.
    Ren Q; Van Groeningen CJ; Hardcastle A; Aherne GW; Geoffroy F; Allegra CJ; Johnston PG; Grem JL
    Oncol Res; 1997; 9(2):77-88. PubMed ID: 9167189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. L-histidinol increases the vulnerability of cultured human leukemia and lymphoma cells to anticancer drugs.
    Warrington RC; Cheng I; Zhang L; Fang WD
    Anticancer Res; 1993; 13(6A):2107-12. PubMed ID: 8297120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytotoxic synergy between pyrazoloacridine (NSC 366140) and cisplatin in vitro: inhibition of platinum-DNA adduct removal.
    Adjei AA; Budihardjo II; Rowinsky EK; Kottke TJ; Svingen PA; Buckwalter CA; Grochow LB; Donehower RC; Kaufmann SH
    Clin Cancer Res; 1997 May; 3(5):761-70. PubMed ID: 9815747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pretreatment of colon carcinoma cells with Tomudex enhances 5-fluorouracil cytotoxicity.
    Longo GS; Izzo J; Chang YM; Tong WP; Zielinski Z; Gorlick R; Chou TC; Bertino JR
    Clin Cancer Res; 1998 Feb; 4(2):469-73. PubMed ID: 9516938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of intermediate-dose methotrexate and high-dose 5-fluorouracil as sequential combination chemotherapy in refractory breast cancer and as primary therapy in metastatic adenocarcinoma of the colon.
    Tisman G; Wu SJ
    Cancer Treat Rep; 1980; 64(8-9):829-35. PubMed ID: 7448820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined actions of 5-fluorouracil and 1-(2-chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea on human colonic carcinoma cells in vitro.
    Sutton JE; Roos IA; Hillcoat BL
    Cancer Res; 1982 Dec; 42(12):5172-5. PubMed ID: 7139620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative effects of selected drug combinations on the growth of a human pancreatic carcinoma cell line (MIA PaCa-2).
    Fountzilas G; Gratzner H; Lim LO; Yunis AA
    J Natl Cancer Inst; 1986 Jan; 76(1):37-43. PubMed ID: 3455740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flow cytometric analysis of cell-killing actions of 5-fluorouracil in human colorectal cancer cells.
    Inaba M; Mitsuhashi J
    Oncol Res; 1994; 6(7):303-9. PubMed ID: 7865905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of 5-fluorouracil metabolism and cytotoxicity by antimetabolite pretreatment in human colorectal adenocarcinoma HCT-8.
    Benz C; Cadman E
    Cancer Res; 1981 Mar; 41(3):994-9. PubMed ID: 7459888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of Fatty Acid Synthase (FASN) synergistically enhances the efficacy of 5-fluorouracil in breast carcinoma cells.
    Vazquez-Martin A; Ropero S; Brunet J; Colomer R; Menendez JA
    Oncol Rep; 2007 Oct; 18(4):973-80. PubMed ID: 17786362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of 5-fluorouracil host-toxicity and chemotherapeutic efficacy against human colon tumors by 5-(Phenylthio)acyclouridine, a uridine phosphorylase inhibitor.
    Al Safarjalani ON; Rais R; Shi J; Schinazi RF; Naguib FN; el Kouni MH
    Cancer Chemother Pharmacol; 2006 Nov; 58(5):692-8. PubMed ID: 16528530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Highly selective drug combinations for human colon cancer cells resistant in vitro to 5-fluoro-2'-deoxyuridine.
    Sobrero AF; Handschumacher RE; Bertino JR
    Cancer Res; 1985 Jul; 45(7):3161-3. PubMed ID: 3159475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.